EW · earnings call history
Edwards Lifesciences Q2 FY26 — Strong Sales Growth Across Portfolio, Raised Full-Year Outlook
Read the briefEdwards Lifesciences Q1 FY26 — 12.7% sales growth drives full-year guidance raise
Read the briefEdwards Lifesciences Q4 FY25 — Strong Growth Across All Product Groups and Increased Confidence in 2026 Guidance
Read the briefEdwards Lifesciences Q3 FY25 — Double-Digit Sales Growth and Raised Full-Year Guidance
Read the briefEdwards Lifesciences Q1 FY25 — Strong TMTT Growth and Strategic Milestones Drive Confidence
Read the briefBrowse all US companies on the earnings-call register.